TRIM54 and cardiomyopathy: Therefore, we measured the amount of O-GlcNAc proteins in MuRF3−/− hearts, hypothesizing that the loss of MuRF3 cleared fewer O-GlcNAc-modified proteins to mediate the enhanced cardiomyopathy seen in vivo.